ARM is contraindicated in:
**Core Concept**
Active Rejection Management (ARM) is a treatment strategy used in the management of acute rejection in renal transplant patients. It involves the use of corticosteroids and other immunosuppressive agents to reduce inflammation and prevent further rejection. The goal of ARM is to prevent long-term damage to the transplanted kidney and maintain graft function.
**Why the Correct Answer is Right**
ARM is contraindicated in cases of **severe acute rejection**, where the rejection is so severe that the kidney is at risk of irreversible damage. In such cases, the use of corticosteroids and other immunosuppressive agents may not be sufficient to prevent further damage, and other treatments such as plasmapheresis or antibody removal may be required.
**Why Each Wrong Option is Incorrect**
**Option A:** is incorrect because ARM is not contraindicated in cases of mild acute rejection, where the use of corticosteroids and other immunosuppressive agents may be effective in preventing further rejection.
**Option B:** is incorrect because ARM is not contraindicated in cases of chronic rejection, where the use of corticosteroids and other immunosuppressive agents may be effective in slowing down the progression of the disease.
**Option C:** is incorrect because ARM is not contraindicated in cases of delayed graft function, where the use of corticosteroids and other immunosuppressive agents may be effective in preventing further rejection and promoting graft function.
**Clinical Pearl / High-Yield Fact**
It is essential to recognize the signs and symptoms of severe acute rejection, including decreased urine output, increased creatinine levels, and hypertension, and to initiate appropriate treatment promptly to prevent long-term damage to the transplanted kidney.
**Correct Answer:** C.